Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
Crossref DOI link: https://doi.org/10.2337/dc14-2830
Published Online: 2015-07-07
Published Print: 2015-09-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Skyler, Jay S.
Fonseca, Vivian A.
Segal, Karen R.
Rosenstock, Julio
Funding for this research was provided by:
Mesoblast Inc.